- Home
- WLDS vs PRFX Comparison
WLDS vs PRFX Comparison
Compare WLDS & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLDS
- PRFX
- Stock Information
- Founded
- WLDS 2014
- PRFX 2007
- Country
- WLDS Israel
- PRFX Israel
- Employees
- WLDS N/A
- PRFX N/A
- Industry
- WLDS Computer Communications Equipment
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- WLDS Telecommunications
- PRFX Health Care
- Exchange
- WLDS Nasdaq
- PRFX Nasdaq
- Market Cap
- WLDS 2.4M
- PRFX 2.8M
- IPO Year
- WLDS 2022
- PRFX 2020
- Fundamental
- Price
- WLDS $6.10
- PRFX $1.38
- Analyst Decision
- WLDS
- PRFX Hold
- Analyst Count
- WLDS 0
- PRFX 1
- Target Price
- WLDS N/A
- PRFX N/A
- AVG Volume (30 Days)
- WLDS 23.1M
- PRFX 8.8M
- Earning Date
- WLDS 09-09-2025
- PRFX 09-30-2025
- Dividend Yield
- WLDS N/A
- PRFX N/A
- EPS Growth
- WLDS N/A
- PRFX N/A
- EPS
- WLDS N/A
- PRFX N/A
- Revenue
- WLDS $422,000.00
- PRFX N/A
- Revenue This Year
- WLDS N/A
- PRFX N/A
- Revenue Next Year
- WLDS N/A
- PRFX N/A
- P/E Ratio
- WLDS N/A
- PRFX N/A
- Revenue Growth
- WLDS N/A
- PRFX N/A
- 52 Week Low
- WLDS $1.00
- PRFX $1.25
- 52 Week High
- WLDS $25.52
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- WLDS 66.49
- PRFX 46.32
- Support Level
- WLDS $1.00
- PRFX $1.33
- Resistance Level
- WLDS $11.40
- PRFX $1.47
- Average True Range (ATR)
- WLDS 1.17
- PRFX 0.11
- MACD
- WLDS 0.69
- PRFX -0.02
- Stochastic Oscillator
- WLDS 49.04
- PRFX 12.50
About WLDS Wearable Devices Ltd.
Wearable Devices Ltd develops and sells human-machine interface solutions for the smart wearables industry. These digital devices include consumer electronics, smart watches, smartphones, AR glasses, VR headsets, televisions, PCs, laptop computers, drones, robots, etc. The company has completed the transition phase from research and development to commercialization of technology into B2B and B2C products. Its products include Mudra Inspire, a band for the Apple Watch that allows touchless operation and control of Apple ecosystem devices such as iPhone, Mac computer, Apple TV, and iPad, inter alia.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.